Amit Munshi
CIK 1612551 · President and CEO · last filed 2026-06-09
Amit Munshi is a President and CEO who has filed 58 SEC Form 4 insider transactions across 8 companies since 2014. The most recent filing, for ARQT, was dated Jun 9, 2026. Across all open-market trades the lifetime net is −$27.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.79M
8
58
-$27.27M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARQT | Director | 9,799 | $24.38 | $238.9K | $0 | 2 | 2026-06-09 |
| IKT | Director | 403,176 | $1.67 | $673.3K | $500.1K | 5 | 2026-02-24 |
| Damora Therapeutics, Inc. (GLTO) Delisted | Director | 4,793 | $28.69 | $137.5K | $0 | 5 | 2025-06-20 |
| ZURA | Director | 777,384 | $3.70 | $2.88M | $0 | 3 | 2025-05-22 |
| Zura Bio Ltd (ZURAW) Delisted | Director | 777,384 | $1.08 | $839.6K | $1000.0K | 3 | 2024-04-24 |
| ARENA PHARMACEUTICALS INC (ARNA) Delisted | President and CEO | 114,647 | $99.99 | $11.46M | -$28.99M | 24 | 2022-03-11 |
| PULM | Director | — | $1.40 | — | $0 | 6 | 2021-02-01 |
| EPIRUS Biopharmaceuticals, Inc. (EPRS) Delisted | Chief Executive Officer | 301,841 | — | — | $221.8K | 10 | 2016-03-01 |
Recent Filings
58 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-09 | ARQT | Grant (A) | +5,778 | $0 | EDGAR |
| 2026-02-24 | IKT | Disp (D) | −19,089 | $0 | EDGAR |
| 2025-12-08 | ARQT | Grant (A) | +2,021 | $0 | EDGAR |
| 2025-08-28 | IKT | Grant (A) | +57,265 | $0 | EDGAR |
| 2025-07-02 | IKT | Grant (A) | — | $0 | EDGAR |
| 2025-06-20 | Damora Therapeutics, Inc. (GLTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-05-22 | ZURA | Grant (A) | — | $0 | EDGAR |
| 2025-02-19 | IKT | Grant (A) | — | $0 | EDGAR |
| 2024-12-11 | ZURA | Grant (A) | — | $0 | EDGAR |
| 2024-10-23 | IKT | Mixed | +365,000 | $500.1K | EDGAR |